CPDR Patient Education Program
Agent Orange and Prostate Cancer
Veterans diagnosed with prostate cancer may qualify for service-connected disability compensation.
Special Clinic at WRNMMC for Men with Prostate Cancer
The Center for Prostate Disease Research (CPDR) at Walter Reed National Military Medical Center (WRNMMC) has a special clinic for men diagnosed with prostate cancer called the "Multi-Disciplinary Prostate Cancer Clinic".
Patient Education Links
American Cancer Society
National Cancer Institute
National Comprehensive Cancer Network
Us TOO International Prostate Cancer Education and Support Network
American Urological Association
Prostate Cancer Research Institute
The John Hopkins Prostate Bulletin
Us TOO Hotsheets
WRNMMC Us TOO Newsletter
August 21, 2014
ERG Monoclonal Antibody [9FY] Patent Issued To The Uniformed Services University Of The Health Sciences Center For Prostate Disease Research & Biocare Medical
Concord, CA – The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. has been awarded a patent in the United States (Patent No: US 8,765,916 B2) and Europe for ERG monoclonal antibodies. The patent is pending in Australia, Canada and Japan. ERG mouse antibody 9FY is a rigorously characterized antibody for its specificity of the ERG protein detection among the closely related members of the ETS transcription factor family in biological specimens.
Read Full Article
August 6, 2014
Genomic Health Announces Positive Topline Results of Additional, Large Independent Validation Study of Oncotype DX® Prostate Cancer Test with Multiple Clinical Endpoints
Redwood City, CA – PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX® Genomic Prostate Score (GPS) predicts multiple clinical endpoints related to disease aggressiveness in men with low- and intermediate-risk prostate cancer. This study validated the Oncotype DX prostate cancer test as a ...
Read Full Article
WRNMMC UsToo! Newsletter
Read the AUGUST 2014 Newsletter